Integration of Liquid Biopsy for Optimal Management of Non-small Cell Lung Cancer by Yuko Oya, Ichidai Tanaka, Ross A. Soo

Get full text

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer by Azhar Ali, Elena Levantini, Jun Ting Teo, Julian Goggi, John G Clohessy, Chan Shuo Wu, Leilei Chen, Henry Yang, Indira Krishnan, Olivier Kocher, Junyan Zhang, Ross A Soo, Kishore Bhakoo, Tan Min Chin, Daniel G Tenen

Get full text

What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer? by Sun Min Lim, MD, PhD, Joo Sung Gabriel Shim, MD, Hyo Sup Shim, MD, PhD, Junko Tanizaki, MD, PhD, Jorn Nutzinger, MD, Byoung Chul Cho, MD, PhD, Ross A. Soo, MBBS, PhD

Get full text

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies by Joan R. Choo, Santhiay Nathan Jeraj, Raghav Sundar, Wei Peng Yong, Matilda Lee, Yiqing Huang, Yugarajah Asokumaran, Gloria H. J. Chan, Natalie Y. L. Ngoi, Andrea L. A. Wong, Ross A. Soo, Cheng Ean Chee, Joline S. J. Lim, Boon Cher Goh, Soo Chin Lee, David S. P. Tan

Get full text

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer by Dana Wai Yi Tsui, Muhammed Murtaza, Alvin Seng Cheong Wong, Oscar M Rueda, Christopher G Smith, Dineika Chandrananda, Ross A Soo, Hong Liang Lim, Boon Cher Goh, Carlos Caldas, Tim Forshew, Davina Gale, Wei Liu, James Morris, Francesco Marass, Tim Eisen, Tan Min Chin, Nitzan Rosenfeld

Get full text

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer by Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung‐Ho Pyo, Eun Joo Shin, Hyo Sup Shim, Ross A Soo, James Chih‐Hsin Yang, Sung Sook Lee, Hyun Chang, Min Hwan Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho

Get full text

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies by Chia-Chi Lin, Elena Garralda, Patrick Schöffski, David S. Hong, Lillian L. Siu, Miguel Martin, Michela Maur, Rina Hui, Ross A Soo, Joanne Chiu, Tian Zhang, Brigette Ma, Chrisann Kyi, Daniel SW Tan, Philippe A. Cassier, John Sarantopoulos, Andrew Weickhardt, Richard D. Carvajal, Jennifer Spratlin, Taito Esaki, Fréderic Rolland, Wallace Akerley, Barbara Deschler-Baier, Lawrence Rispoli, Tanay S. Samant, Niladri Roy Chowdhury, Daniel Gusenleitner, Eunice L. Kwak, Vasileios Askoxylakis, Filippo De Braud

Get full text